Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.

Lawn, SD; (2011) Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes. The international journal of tuberculosis and lung disease, 15 (9). pp. 1272-3. ISSN 1027-3719 DOI: https://doi.org/10.5588/ijtld.11.0407

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.5588/ijtld.11.0407

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar